the cytoplasm, thereby activating contractile proteins (Somlyo and Somlyo, 1970; Johansson, 1978; Winquist and Bevan, 1980) . There are two main sources of activator Ca 2+ , namely, the pool of extracellular Ca 2+ including ions loosely bound to the external muscle membrane and the tightly bound Ca 2+ which is sequestered inside the muscle fiber, especially within the cell membrane, sarcoplasmic reticulum, and mitochondria (Hurwitz and Suria, 1971; Bohr, 1978; Johansson, 1978; van Breeman et al., 1979) . Different contractile agonists have been CALCIUM AND MESENTERIC 693 shown to influence the two sources of Ca 2+ differently. For instance, contraction induced by depolarizing concentrations of potassium is the result of an augmented flux of Ca 2+ from the extracellular space, whereas the vasoconstriction induced by norepinephrine involves primarily the release of intracellular Ca 2+ (Hudgins and Weiss, 1968; Seidel and Bohr, 1971; Godfraind and Kaba, 1972; Bohr, 1978) .
Effects of Ca 2+ on the intestinal circulation have not been studied extensively and vascular responses appear minimal (Chou et al., 1963; Dabney et al., 1967; Pawlik et al., 1975) . Furthermore, calcium ionophores are minimally active (Hanley et al., 1975; Lanciault et al., 1976) . Recently, a group of chemically different compounds was introduced which are believed to exert a negative inotropic effect and relax vascular smooth muscle by a selective inhibition of membrane Ca 2+ flux, i.e., by reducing the slow inward current (Fleckenstein, 1977; Fleckenstein and Fleckenstein-Griin, 1977) .
Effects of calcium antagonists in the intestinal circulation have received little attention (Schwaiger et al., 1979) . These compounds are potent coronary vasodilators, relaxing primarily the smooth muscle of large arteries, and, therefore, are potentially useful in clinical entities involving spasm or arteriosclerotic changes of these vessels (Fleckenstein and Fleckenstein-Griin, 1977) . Since such pathological changes also occur in the mesenteric vasculature (Marston, 1977; Bynum and Jacobson, 1979 ) a search among the calcium antagonists for a potentially useful agent for the management of intestinal ischemia would appear justified.
The aim of our present study was to investigate the effects of calcium and two calcium antagonists, nifedipine and diltiazem, on the intestinal circulation, its oxygen consumption, and the distribution of intestinal blood flow in vivo. Attempts also were made to elucidate the mechanism of action of nifedipine on mesenteric arterial smooth muscle in vitro.
Methods
A total of 29 mongrel dogs of both sexes, weighing between 16 and 28 kg (average 20.6 kg) were used in this study. Of these animals, 25 were studied under in vivo conditions, and four dogs were used to obtain mesenteric arteries for in vitro experiments. All animals were deprived of food for 24 hours and anesthetized with intravenous (iv) injection of sodium pentobarbital (30 mg/kg).
In Vivo Experiments
After endotracheal intubation, ventilation was maintained with a positive pressure respirator (Harvard Apparatus) at a rate adjusted to body weight. A femoral artery was cannulated and connected to a pressure transducer (Hewlett-Packard) for recording the arterial pressure and for siphoning arterial blood into one cuvette of a spectrophotometric oxygen content difference analyzer (A-VOX Systems) (Shepherd and Burgar, 1977) . Another femoral artery was used to introduce a catheter into the left ventricle for injection of radiolabeled microspheres. Both femoral veins were also catheterized to return the blood from the oxygen analyzer and for injections of drugs and supplemental anesthetic.
After midline laparotomy, a distal trunk of the superior mesenteric artery supplying the terminal ileum was exposed and its side branch cannulated for intraarterial (ia) infusions of the substances under study. An electromagnetic flow probe of 2.0 to 3.0 mm i.d. was positioned around the mesenteric artery and connected to a blood flow amplifier (Zepeda Instruments). The flowmeter was calibrated in each experiment by transient occlusion of the mesenteric artery distal to the flow probe. A side branch of the superior mesenteric vein was also cannulated to siphon venous blood continuously from the segment under study to the oxygen analyzer. Both ends of the ileal segment were ligated to exclude collateral circulation.
A wide-bore, saline-filled, multihole catheter was inserted through the proximal end into the lumen of the ileal segment and was connected to a pressure transducer (Hewlett-Packard) for measurements of intraluminal pressure. The measured parameters included the systemic arterial pressure, arteriovenous oxygen content difference (A-Vo 2 ), blood flow (BF), and intraluminal pressure (IP). These measurements were recorded continuously on a direct writing recorder (Hewlett-Packard, model 7759A). Intestinal oxygen consumption (Vo 2 ) was calculated as the product of A-Vo 2 and BF in ml 0 2 /min per 100 g of intestine. After heparin (250 USP/kg, Panheprin, Abbott) was injected, the cuvettes of the oxygen analyzer were perfused with arterial and venous blood by a constant flow pump (Holter) at 5.5 ml/min.
Changes in blood flow distribution within the intestinal wall were assessed with four radiolabeled microspheres ( H1 Ce, 51 Cr, 85 Sr, and 46 Sc) of 15 ± 3 pim diameter (3M Co.) injected into the left ventricle during a control period and during administration of drugs. After each experiment, control and experimental intestinal segment were removed, rinsed, and weighed. Segments were opened along the mesenteric border and cut into portions about 10 cm long. The mucosal and submucosal layers were stripped from the muscularis and counted in a y spectrometer (Packard Instruments). Corrections were made for overlap in the energy spectra. Fractional blood flow to the mucosal-submucosal compartment (FBFm-s ) was calculated as the product of BF and the percentage of microspheres distributed to the mucosa-submucosa (m-s) and was expressed in ml/min per 100 g of intestine.
Following surgery and a 30-minute stabilization period, dose-response curves for ia infusions of nifedipine (Pfizer Pharmaceuticals), diltiazem (Mar-ion Laboratories) (both agents infused at 0.1, 1.0, and 10.0 jug/kg per min), or calcium chloride (CaCl 2 at 1.0, 10.0, 100.0, 500.0, and 1,000.0 jug/kg per min) were obtained.
Extreme care was taken to minimize the exposure of nifedipine to light. This was accomplished by weighing the drug in a dark room on a balance having an illuminated dial and dissolving the agent in a solution (ethanol 15%, polyethylene glycol 15% in saline) contained in a flask covered with aluminum foil in a room with faint indirect light. The infusion pump syringe containing dissolved nifedipine and the polyethylene tubine conveying the drug to the mesenteric artery were wrapped in aluminum foil. The pump, syringe, tubing, and dog were covered with surgical towels throughout the experiment. In another series of experiments, the effects of nifedipine (0.1 jug/kg per min) on responses to CaCl 2 (500.0 jug/kg per min) or norepinephrine (0.1 jug/kg per min) were investigated by infusing each of the constrictors with nifedipine. The duration of infusion with each agent was 10 minutes.
In an additional series of experiments, an attempt was made to explore the unexpected vasodilator effect of the highest dose of CaCl 2 . First, the effects of ia infusions of comparably hyperosmotic (1100 mOsm) solutions of NaCl (3.6%) or mannitol (20%) were assessed. Second, the dilator dose of CaCU was infused after iv administration of digoxin (Lanoxin, Burroughs-Wellcome Co., 50 jug/kg).
In Vitro Experiments
Four additional dogs were used to obtain muscle strips from the superior mesenteric artery. Following anesthesia and laparotomy the vessel was quickly excised, carefully cleaned of surrounding tissues, and opened longitudinally. Strips of circular muscle 10 to 12 mm long and 2 mm wide were then cut. Four strips were mounted in a single muscle chamber with one end of each strip fixed to the glass post and the other end connected with silk thread to a Grass FT 0.03 transducer. Strips were suspended in 20 ml of physiological salt solution (PSS) aereated with 95% 0 2 :5% CO 2 gas mixture and maintained at 37°C. The composition of the PSS was (in miw): NaCl, 130.0; NaHC0 3 , 14.9; KC1, 4.7; KH 2 PO 4 , 1.19; MgSC-4 • 7H 2 O, 1.17, CaCl 2 • 2H 2 O, 1.6; CaNa 2 , versenate, 0.026; and dextrose 5.5. Two modifications of PSS also were used, namely, CaCl 2 -free PSS, and CaCl 2 -free PSS to which 100 / XM EGTA (ethylene glycol-bis-(beta-aminoethylether)-N-iV'-tetracetic acid) had been added to reduce further the activity of any contaminating Ca 2+ . Strips were stretched passively to optimal length for development of tension by imposing a resting tension of 5 g (calculated according to the law of Laplace). Contractile activity was detemined as isometric tension on a Grass model 7 polygraph.
Following a 2-hour period of equilibration, the passive tension was reapplied and the strips were challenged with 50 mM potassium chloride (KC1) until the response obtained was reproducible. Then strips were contracted by adding either KC1 to give a concentration of 30 mM or 0.1 JXM norepinephrine (Levophed bitartrate, Winthrop Laboratories) in order to compare the potency of agonists, and to assess possible changes in tension related to time. Reproducibility of contractile responses to both agonists in each type of PSS was also evaluated in separate experiments in which strips were repetitively contracted at 20-minute intervals. Cumulative dose-response curves (10~9 to 10~5 M) for nifedipine were determined in strips contracted with 30 mM KC1 or 0.1 JUM norepinephrine in normal PSS, in strips contracted with 0.1 JUM norepinephrine in Ca 2+ -free PSS and Ca 2+ -free PSS with EGTA, and in strips 20 minutes after obtaining dose-response relationships for nifedipine and washing the chambers several times with appropriate PSS. The response of strips to KC1 and norepinephrine were assessed again a few times during the subsequent 2 to 3 hours following drug washout.
Measurements used for statistical analyses under in vivo conditions were obtained at the time of injections of microspheres to correlate changes in distribution of blood flow with those of total blood flow or oxygen consumption. Results have been expressed as the mean percentage of control values ± standard errors of the means (SEM). Changes from control values under both in vivo and in vitro conditions were analyzed with a paired £-test and the differences between series of experiments were analyzed with a pooled i-test. Differences were considered significant at a probability of less than 0.05. Only those changes which were significant are cited in the Results section.
Results

In Vivo Studies
Control values for 25 dogs were: BF 65.6 ± 4.7 ml/min per 100 g of intestinal tissue, A-Vo 2 3.1 ± 0.3 ml O 2 /ml of blood, Vo 2 2.0 ± 0.2 ml 0 2 /min per 100 g of intestine, the fraction of total blood flow which perfused the muscularis 30.6 ± 3.5%, m-s 69.4 ± 3.5%, FBF m . s 45.0 ± 3.4 ml/min per 100 g of intestine, and IP 4.8 ± 0.7 mm Hg. Systemic arterial pressure was not changed significantly during any series of tests. The weight of intestinal segments averaged 208.5 g.
Infusion of the three doses of nifedipine produced a dose-dependent increase in BF and decreases in A-Vo 2 and IP. The two higher doses of nifedipine also caused increases in m-s and FBF m . s . The calculated dose of the drug producing a 50% increase in BF was 0.36 /ig/kg per min or 1 X 10~9 mol/kg per min (Fig. 1) .
Diltiazem evoked similar responses, but was less potent. The calculated dose of diltiazem causing a 50% increase in BF was 3.3 /xg/kg per min or 7.3 X 10~9 mol/kg per min (Fig. 2) . After cessation of infusion of either agent, all measured parameters returned to control within a few minutes.
CaCl 2 produced a dose-dependent decrease in BF up to a dose of 500.0 jug/kg per min. At a dose of 1,000.0 jug/kg per min, CaCl 2 caused a significant increase in BF. A-Vo 2 was increased at all doses of CaCl 2 , although at lowest and highest doses the changes were not significant. Vo 2 changed significantly only at the 1,000.0 jig/kg per min dose, when it increased (Fig. 3) . IP increased in a dose-dependent manner with the 100.0, 500.0, and 1,000.0 jug/ kg per min doses of CaCl 2 . The intestinal contractions were of both rhythmic and tonic type and were observed mainly at the beginning of infusion of each dose. Since the distribution of microspheres was not changed significantly at any dose, changes in FBF m . s paralleled those of BF. These data were omitted for the sake of clarity.
The lowest dose of nifedipine, infused together with the highest constrictor dose of CaCl 2 , completely blocked the effects of CaCl 2 . Thus, the effects of nifedipine + CaCl 2 were not significantly different from those of nifedipine alone (Fig. 4) . Nifedipine also partially inhibited the vasoconstrictor response to norepinephrine. Control infusion of the catecholamine decreased BF, Vo 2 , m-s and FBF m -s and increased A-Vo 2 . Norepinephrine infused with nifedipine produced significantly smaller changes in all parameters except Vo 2 than did norepinephrine alone (Fig. 5) .
Digoxin reduced BF and Vo 2 and increased AVo 2 (Fig. 6 ). CaCl 2 (1,000.0 jug/kg per min) infused 10-15 minutes after injection of digoxin exerted a small vasoconstrictor effect; thus, BF decreased and A-Vo 2 increased, whereas Vo 2 decreased when compared with control values before digoxin. BF and A-Vo 2 were significantly different from values observed with digoxin alone.
In Vitro Experiments
KC1 (30 HIM) and norepinephrine (0.1 /XM) were equipotent in contracting strips of mesenteric artery in normal PSS, i.e., contractile tensions obtained with both agonists were not significantly different. As shown in Figure tension obtained with KC1 was 8.2 ± 0.8g and that obtained with norepinephrine was 9.6 ± 1.1 g in the same strips. In calcium-free PSS, control tension obtained with KC1 was reduced to 1.5 ± 0.2 g and in the same strips norepinephrine induced a tension of 7.4 ± 1.2 g. These values were significantly dif- ferent (P < 0.001). In calcium-free PSS with EGTA, KCl-contracted strips developed a tension of 0.7 ± 0.1 g, whereas norepinephrine-induced contractions of the same series of strips averaged 5.0 ± 1.1 g. These values again were significantly different (P is less than 0.005). Additional control tests involved repetitive challenges with either agonist in normal PSS and Ca 2+ -free PSS with EGTA. Contractile responses to consecutive challenges with KC1 were not different from one another and were very well sustained so long as the excess of KC1 was not washed out. Responses to consecutive challenges with norepinephrine in normal PSS were also not different from one another and were well sustained; however, in Ca 2+ -free PSS and Ca 2+ -free PSS with EGTA, contractile responses to norepinephrine reached their maxima within 1-2 minutes and then decreased at a steady rate. Therefore, in experiments in which norepinephrine was used as the contractile agonist, before assessing the effects of nifedipine, the rate of spontaneous decrease in tension was established for each strip over a period of 30-35 minutes, and decreases in tension obtained with increasing concentrations of nifedipine then were Figure 1 . duced a concentration-dependent relaxation of KCl-contracted strips in normal PSS and of strips contracted with norepinephrine in normal PSS (Fig.  8) . The ED50 (dose producing 50% relaxation) under these conditions was 7.1 X 10" 7 M in KCI contracted strips and 3.3 X 10~8 M in norepinephrine-contracted strips. The same concentrations of nifedipine relaxed strips contracted by norepinephrine in Ca 2+ -free PSS and in Ca 2+ -free PSS with EGTA. After assessing the dose-response to nifedipine, the strips were washed several times and challenged again after 20 minutes. All responses were significantly depressed (Fig. 7, hatched bars) up to 3 hours after the experiments were terminated.
KCI NORMAL PSS
NIFEDIPINE (M)
Discussion
The results of our in vivo studies indicate that both nifedipine and diltiazem are potent dilators of the intestinal circulation. Comparison of doses producing a 50% increase in blood flow to the ileum shows that nifedipine is about 7 times more potent than diltiazem on a molar basis. It appears that both agents dilate arteriolar resistance vessels in the intestinal circulation, while decreasing the tone of large arteries as an additional effect. The latter effect has been suggested in the coronary circulation (Fleckenstein and Fleckenstein-Griin, 1977) but cannot alone account for such large increases in blood flow to the gut as were observed with these drugs. Vasodilation occurred mainly in the mucosasubmucosa with the calcium antagonists indicating that these compounds produce a redistribution of intestinal blood flow to the mucosal-submucosal compartment. This redistribution may have been related to the decrease in intestinal motor activity observed with these drugs, reflecting the important role of calcium in mediating contractile activity of both vascular and visceral smooth muscle (Anderson et al., 1972) . Dose-related increases in blood flow observed with the calcium antagonists were accompanied by proportional decreases in oxygen extraction across the intestinal circulation and resulted in no change in oxygen consumption by the gut. The lack of change in oxygen uptake suggests that the main micro-circulatory effect of these compounds, relaxation of arterioles, was not accompanied by any apparent relaxation of precapillary sphincters which regulate the nutrient circulation. The increased blood flow which bypasses the nutrient circulation thereby represents a functional arteriovenous shunting. It is also possible that Ca 2+ antagonists depress intestinal function(s) and, therefore, reduce oxygen use by the gut, as has been shown in the myocardium (Fleckenstein, 1977; Fleckenstein and Fleckenstein-Griin, 1977) . Were this the case, the decrease in oxygen utilization would nullify any effect of opening the precapillary sphincters. The more likely of these two explanations cannot be ascertained from our data.
Previous studies of the interactions of calcium antagonists with cardiac glycosides in the coronary and intestinal circulations showed that the antagonists appear to have different effects in the normal and digitalis-poisoned circulations.
In contrast to the high potency of calcium antagonists in the intestinal circulation, Ca 2+ itself evoked very small constrictor effects in this vascular bed. Chou et al. (1963) reported a 10% increase in total intestinal resistance and a 20% increase in small-vessel resistance in response to an isotonic CaCl 2 infusion at a rate of about 8 ml/min. The same group reported later that Ca 2+ relaxed visceral smooth muscles but had no significant effect on intestinal resistance (Dabney et al., 1967) . Infusion of CaCl2 at 300 /xg/kg per min into the mesenteric artery was reported to decrease both blood flow and oxygen consumption by 12% (Pawlik et al., 1975) . Maximal constriction obtained with CaCl 2 in the present study corresponded to about a 20% decrease in blood flow. The dose-dependent decrease in blood flow was accompanied by an increase in oxygen extraction and no change in oxygen uptake, typical of a weak vasoconstrictor effect in this circulation. The highest dose of CaCl 2 (1,000 jug/kg per min) produced, unexpectedly, a reproducible intestinal vasodilation accompanied by an increase in oxygen consumption. In additional experiments not reported here still higher doses of CaCl 2 (2,000.0 and 5,000.0 MgAg per min) prompted progressively greater dilator responses. We thought this vasodilation might be a function of the hyperosmolarity of the CaCl 2 solution infused into the artery, since ia administration of hyperosmolar glucose or NaCl was shown to decrease vascular resistance in the feline intestinal circulation (Levine et al., 1978) . In our study, however, solutions of NaCl or mannitol of the same osmolarity as the 1,000.0 jug/kg per min solution of CaCl 2 infused i.a. did not change any circulatory or metabolic parameter. The vasodilator effect of the 1,000.0 jtig/kg per min dose of calcium may be related to its effect on the membrane-bound Na + ,K + -ATPase of the muscle cell. This enzyme is blocked by cardiac glycosides (Akera, 1977) , and this effect probably accounts for the vasoconstrictor effect of digitalis in the intestinal circulation (Pawlik and Jacobson, 1974; Schwaiger et al., 1979) . After blockade of Na + ,K + -ATPase by digoxin, the dilator effect of the highest dose of CaCl 2 was converted to a constrictor effect.
None of the doses of CaCl 2 changed the distribution of intestinal blood flow, suggesting that vasoconstriction or vasodilation was proportional in all intestinal layers. The three higher doses of CaCl 2 also stimulated intestinal motility, a finding which is not in agreement with reports of others wherein a decrease in tone of intestinal musculature was observed with Ca 2+ (Dabney et al., 1967) . The stimulation of intestinal motility by Ca 2+ is, however, consistent with the inhibitory effects on motility we observed with calcium antagonists and suggests that qualitative similarities exist between the role of Ca 2+ in contractility of vascular and nonvascular smooth muscle. The suggestion that effects of ions on visceral smooth muscle may interfere with their action on vascular resistance (Chou et al., 1963; Dabney et al., 1967) appears unlikely, since a doserelated increase in intraluminal pressure was found with the three highest doses of CaCk, whereas intestinal blood flow was first diminished and then augmented (at highest dose when the amplitude of intestinal contractions was highest). Our observations suggest different sensitivities of vascular and visceral smooth muscle to the increments of plasma Ca 2+ concentrations. Ca 2+ may act through several mechanisms in vascular smooth muscles. First, a rise in extracellular Ca 2+ increases the transmembrane concentration gradient, the membrane Ca 2+ influx, and the intracellular concentration of the ion. This effect is not very pronounced, probably because much of the Ca 2+ entering the cell is easily sequestered in intracellular stores before it can activate contractile proteins. Second, Ca 2+ may stabilize the cell membrane or may stimulate Na + , K + -ATPase. Inhibition of vascular tone in vitro by supranormal extracel-lular concentrations of Ca 2+ has been shown previously (Winquist and Bevan, 1980) . Whether this effect occurs over the entire range of concentrations and thus minimizes the direct constrictor effect or occurs only at very high concentrations remains to be established in studies of the direct effects of calcium on isolated enzymes.
Nifedipine completely blocked the circulatory effects of the highest constrictor dose of calcium but only partially reduced the constrictor response of the intestinal circulation to norepinephrine. It is possible that reduction of norepinephrine-induced constriction reflects the ability of nifedipine to block increased Ca 2+ influx which accounts in part for the constrictor action of the drug (Seidel and Bohr, 1971; Godfraind and Kaba, 1972; Bohr, 1978; Johannson, 1978; Meisheri et al., 1980) . Nifedipine is commonly believed to interfere with the slow inward current, i.e., transmembrane Ca 2+ influx, or to reduce the number of slow channels (Fleckenstein, 1977; Fleckenstein and Fleckenstein-Griin, 1977; Bayer and Ehara, 1978 ; but an effect on intracellular calcium release has also been proposed (Church and Zsoter, 1980) . Under in vitro conditions, nifedipine appeared to be a very effective relaxant of mesenteric arterial strips contracted with either norepinephrine or KC1 and produced almost complete relaxation whether or not extracellular calcium was present in the medium. It is well established that KCl-induced contraction uses extracellular calcium whereas norepinephrine-mediated contraction depends on both extra-and intracellular Ca 2+ (Hudgins and Weiss, 1968; Seidel and Bohr, 1971; Godfraind and Kaba, 1972; Bohr, 1978; Meisheri et al., 1980 ) van Breeman et al., 1979 . The ED50 of nifedipine fed norepinephrine-contracted strips was more than one order of magnitude lower than for KCl-contracted strips. This difference may mean that nifedipine relaxes vascular smooth muscle both by blocking Ca 2+ influx and by preventing Ca 2+ release from intracellular stores.
To exclude Ca 2+ influx, we performed studies on the norepinephrine-nifedipine interaction after removing Ca 2+ from the external medium. In both Ca 2+ -free PSS and Ca 2+ -free PSS with EGTA, norepinephrine still produced contraction, in contrast to KC1. This differential effect of Ca 2+ removal on vascular smooth muscle from rat aorta was demonstrated previously by Hudgins and Weiss (1968) , and our results confirm their findings. Contractions obtained with norepinephrine after removal of Ca 2+ were not sustained. This finding is consistent with the suggestion that the tonic response to norepinephrine is due to increased uptake of external Ca 2+ in contrast to the phasic (initial) response which depends upon release of Ca 2+ from internal stores (Godfraind and Kaba, 1972) . The difference probably is not discrete because phasic responses to norepinephrine in normal, Ca 2+ -free and Ca 2+ -free PSS with EGTA differ significantly. On the other hand, a part of the tonic response may also depend on intracellular Ca 2+ release since the decrease in tension after norepinephrine was relatively slow in the absence of Ca 2+ . Addition of nifedipine in increasing concentrations accelerated the spontaneous decay of tension.
Nifedipine irreversibly blocked any subsequent responses to KC1 or norepinephrine in any type of PSS. Thus, the drug interferes not only with KClinduced contraction and the tonic response to norepinephrine, both of which depend mainly on extracellular Ca 2+ , but also with the phasic response to the catecholamine. release from intracellular sites. Increased Ca 2+ efflux is also possible as a mechanism of nifedipineinduced relaxation (Fleckenstein and FleckensteinGriin, 1977) . Our results generally confirm the results of studies of Ca 2+ fluxes under the influence of calcium antagonists (Church and Zsoter, 1980) . The quantitative contribution of the preceding mechanisms to the vasodilator effects of these compounds cannot be established at this point.
In Ca
2+
-free media, maximum relaxation of norepinephrine-contracted strips is much less than that of norepinephrine or KCl-contracted strips in the presence of Ca 2+ . Furthermore, at low concentrations of nifedipine, relaxation of strips contracted with norepinephrine in all types of PSS is similar to relaxation of strips contracted with KC1. These findings support the speculation that Ca 2+ antagonists in low doses interact in a major way with the intracellular free Ca 2+ pool. When the concentration of the drug is high, these drugs also affect membrane calcium flux, and produce additional relaxation. It is possible that studies of calcium fluxes in vascular smooth muscle might bear upon these speculations, although recent experiments (Church and Zsoter, 1980) using such techniques did not appear to yield definitive results.
